Cilazapril: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 23: Line 23:
| routes_of_administration =  
| routes_of_administration =  
}}
}}
__NOTOC__
{{SI}}
{{CMG}}


{{CMG}} {{SS}}
==Overview==
'''Cilazapril''' is an [[angiotensin-converting enzyme]] inhibitor ([[ACE inhibitor]]) used for the treatment of [[hypertension]] and [[congestive heart failure]].<ref>{{cite book|title=Austria-Codex|editor=Jasek, W|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2007|edition=2007/2008|isbn=978-3-85200-181-4|language=German}}</ref> It is branded as '''Inhibace''' in Canada and other countries, '''Vascace''' and '''Dynorm''' in a number of European countries, among many other names. None of these are available in the [[United States]] as of May 2010.<ref>Drugs.com: [http://www.drugs.com/international/cilazapril.html Cilazapril]</ref>


'''Cilazapril''' is an [[angiotensin-converting enzyme]] inhibitor ([[ACE inhibitor]]) used for the treatment of [[hypertension]] and [[congestive heart failure]].<ref>{{cite pmid|1712267}}</ref><ref>{{cite book|title=Austria-Codex|editor=Jasek, W|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2007|edition=2007/2008|isbn=978-3-85200-181-4|language=German}}</ref> It is branded as '''Inhibace''' in Canada and other countries, '''Vascace''' and '''Dynorm''' in a number of European countries, among many other names. None of these are available in the [[United States]] as of May 2010.<ref>Drugs.com: [http://www.drugs.com/international/cilazapril.html Cilazapril]</ref>
Of the eight possible [[stereoisomers]], only the all-''S'' form is medically viable.
 
Of the eight possible [[stereoisomers]], only the all-''S'' form is medically viable.{{citation needed|date=February 2012}}


==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:ACE inhibitors]]
[[Category:ACE inhibitors]]
[[Category:Lactams]]
[[Category:Cardiovascular Drugs]]
[[Category:Carboxylic acids]]
[[Category:Drug]]
[[Category:Cardiovascular Drugs]][[Category:Drugs]]
 
{{WikiDoc Help Menu}}

Latest revision as of 20:49, 23 July 2014

Cilazapril
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC22H33N3O6
Molar mass435.514 g/mol

WikiDoc Resources for Cilazapril

Articles

Most recent articles on Cilazapril

Most cited articles on Cilazapril

Review articles on Cilazapril

Articles on Cilazapril in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cilazapril

Images of Cilazapril

Photos of Cilazapril

Podcasts & MP3s on Cilazapril

Videos on Cilazapril

Evidence Based Medicine

Cochrane Collaboration on Cilazapril

Bandolier on Cilazapril

TRIP on Cilazapril

Clinical Trials

Ongoing Trials on Cilazapril at Clinical Trials.gov

Trial results on Cilazapril

Clinical Trials on Cilazapril at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cilazapril

NICE Guidance on Cilazapril

NHS PRODIGY Guidance

FDA on Cilazapril

CDC on Cilazapril

Books

Books on Cilazapril

News

Cilazapril in the news

Be alerted to news on Cilazapril

News trends on Cilazapril

Commentary

Blogs on Cilazapril

Definitions

Definitions of Cilazapril

Patient Resources / Community

Patient resources on Cilazapril

Discussion groups on Cilazapril

Patient Handouts on Cilazapril

Directions to Hospitals Treating Cilazapril

Risk calculators and risk factors for Cilazapril

Healthcare Provider Resources

Symptoms of Cilazapril

Causes & Risk Factors for Cilazapril

Diagnostic studies for Cilazapril

Treatment of Cilazapril

Continuing Medical Education (CME)

CME Programs on Cilazapril

International

Cilazapril en Espanol

Cilazapril en Francais

Business

Cilazapril in the Marketplace

Patents on Cilazapril

Experimental / Informatics

List of terms related to Cilazapril

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cilazapril is an angiotensin-converting enzyme inhibitor (ACE inhibitor) used for the treatment of hypertension and congestive heart failure.[1] It is branded as Inhibace in Canada and other countries, Vascace and Dynorm in a number of European countries, among many other names. None of these are available in the United States as of May 2010.[2]

Of the eight possible stereoisomers, only the all-S form is medically viable.

References

  1. Jasek, W, ed. (2007). Austria-Codex (in German) (2007/2008 ed.). Vienna: Österreichischer Apothekerverlag. ISBN 978-3-85200-181-4.
  2. Drugs.com: Cilazapril